Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients.

Victor, Victor M

Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients. [electronic resource] - Atherosclerosis Sep 2015 - 167-73 p. digital

Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1879-1484

10.1016/j.atherosclerosis.2015.07.017 doi


Adolescent
Adult
Biomarkers--blood
Cell Adhesion--drug effects
Cell Adhesion Molecules--blood
Cells, Cultured
Coculture Techniques
Cytokines--blood
Diabetes Mellitus, Type 2--blood
Endothelial Cells--drug effects
Female
Human Umbilical Vein Endothelial Cells--drug effects
Humans
Inflammation Mediators--blood
Leukocyte Rolling--drug effects
Leukocytes--drug effects
Metformin--therapeutic use
Polycystic Ovary Syndrome--blood
Spain
Time Factors
Treatment Outcome
Young Adult